Treatment of our lymphoma cells with BEZ235 led to a decrease in Aurora A expression, while BKM120 did not alter Aurora A kinase expression, supporting a possible key role of this kinase in cell cycle control. The gene discussed is AURKA; the disease is lymphoma.